Literature DB >> 6153307

Suppressor cell activity in primary biliary cirrhosis.

R K Zetterman, J A Woltjen.   

Abstract

Recent evidence has suggested that peripheral blood suppressor cell populations can modulate immune responsiveness. Absence of suppressor cell activity has been noted in diseases of presumed autoimmune basis. We determined inducible suppressor cell activity in patients with primary biliary cirrhosis (PBC) as compared to age and sex-matched controls. There was a significant loss of suppressor cell activity for mitogen response in patients with PBC (-4.5 +/- 8.0%) versus controls (43.7 +/- 7.8%). No correlation of this loss to clinical parameters was observed. This study suggests PBC patients lack inducible suppressor cell activity provide partial explanation for the perpetuation of this disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6153307     DOI: 10.1007/BF01308306

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Isolation of lymphocytes, granulocytes and macrophages.

Authors:  A Bøyum
Journal:  Scand J Immunol       Date:  1976-06       Impact factor: 3.487

2.  Alteration in suppressor cell activity in chronic active hepatitis.

Authors:  H J Hodgson; J R Wands; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

3.  Antibodies to cytoplasmic antigens in primary biliary cirrhosis and chronic active hepatitis.

Authors:  F Paronetto; F Schaffner; H Popper
Journal:  J Lab Clin Med       Date:  1967-06

4.  Peripheral blood lymphocyte populations in chronic liver disease.

Authors:  H C Thomas; M Freni; J Sanchez-Tapias; D de Villiers; S Jain; S Sherlock
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

5.  Direct evidence for loss of human suppressor cells during active autoimmune disease.

Authors:  A J Strelkauskas; R T Callery; J McDowell; Y Borel; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

6.  Asymptomatic primary biliary cirrhosis. Presentation, histology, and results with D-penicillamine.

Authors:  C R Fleming; J Ludwig; E R Dickson
Journal:  Mayo Clin Proc       Date:  1978-09       Impact factor: 7.616

7.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

8.  Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

Authors:  J Miller; M G Smith; C G Mitchell; W D Reed; A L Eddleston; R Williams
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

9.  Lymphocyte transformation in response to phytohaemagglutinin in primary biliary cirrhosis: the search for a plasma inhibitory factor.

Authors:  R A Fox; F J Dudley; M Samuels; J Milligan; S Sherlock
Journal:  Gut       Date:  1973-02       Impact factor: 23.059

10.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  12 in total

1.  Immune hemolytic anemia and renal failure associated with rifampicin-dependent antibodies with anti-I specificity.

Authors:  A Pereira; C Sanz; F Cervantes; R Castillo
Journal:  Ann Hematol       Date:  1991-07       Impact factor: 3.673

2.  T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls.

Authors:  L Si; T L Whiteside; R R Schade; T E Starzl; D H Van Thiel
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

3.  Decreased T-suppressor cell activity in rats with adjuvant arthritis.

Authors:  L Binderup
Journal:  Ann Rheum Dis       Date:  1983-12       Impact factor: 19.103

Review 4.  Primary biliary cirrhosis associated with features of systemic lupus erythematosus.

Authors:  G D Iliffe; S Naidoo; T Hunter
Journal:  Dig Dis Sci       Date:  1982-03       Impact factor: 3.199

Review 5.  Pathogenic mechanisms in primary biliary cirrhosis.

Authors:  H C Thomas; O Epstein
Journal:  Springer Semin Immunopathol       Date:  1980-12

6.  Spontaneous suppressor cell function in inflammatory bowel disease.

Authors:  R M Victorino; H J Hodgson
Journal:  Dig Dis Sci       Date:  1981-09       Impact factor: 3.199

7.  Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.

Authors:  H F Eggink; H J Houthoff; S Huitema; C H Gips; S Poppema
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

8.  Deficiency of the autologous mixed lymphocyte reaction in patients with primary biliary cirrhosis.

Authors:  S P James; C O Elson; J G Waggoner; E A Jones; W Strober
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

9.  Lymphocytotoxic antibodies in primary biliary cirrhosis.

Authors:  A Parés; J Martorell; J Caballería; J Vives; M Bruguera; J Rodés
Journal:  Dig Dis Sci       Date:  1985-09       Impact factor: 3.199

10.  Circulating activated B cells in primary biliary cirrhosis.

Authors:  S P James; E A Jones; J H Hoofnagle; W Strober
Journal:  J Clin Immunol       Date:  1985-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.